Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-23-000125

Chief Medical Officer sold 2,768 shares at $23.79 ($65,851)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ho Carole Chief Medical Officer 2023-08-14 Sale 10b5-1 −2,768 $23.79 $65,851 182,809 I: show line 1 in the form
Open-market sales · 2,768 sh · avg $23.79 · $65,851
Loading xslF345X05/wk-form4_1692224392.xml…